Name: How the Use of Discovery is Evolving in Inter Partes Review Proceedings
Start: 2013-06-12T17:00

Hosts

Name

Adam Shartzer

Person title

Principal
Name

Timothy W. Riffe

Person title

Principal

During this seminar, we will provide an overview of the discovery rules governing Inter Partes Review (IPR) proceedings, and discuss recent PTAB decisions and how those decisions are shaping the use of discovery during IPR.

How the Use of Discovery is Evolving in Inter Partes Review Proceedings

Hosts

Building the IP Moat: Maximizing Technology Value on the Path to IPO

Teva v. Lilly: Conflicting Positions at PTAB and District Court Sink Patent Challenge

USPTO to Allow Pre-Order Patent Owner Responses in Reexaminations

Congressional Oversight Hearing Highlights Continued PTAB Policy Fault Lines

Federal Circuit Denies All Mandamus Petitions Challenging Discretionary Denial Policies

USPTO Adds Three New Factors to Discretionary Denial Considerations

Biologics and Biosimilars Landscape 2025: IP, Policy, and Market Developments

How To Kill a Weak Patent: 10 Strategies After Being Sued

Lessons From Recent Pharma & Med Device Federal Circuit Decisions

Federal Circuit Declines To Disturb “Settled Expectations” Factor in Denying Mandamus Petitions

Unpacking Appellate Challenges to the USPTO’s Discretionary Denial Framework